Mandate

Opica AB has announced bid regarding Capio AB

September 13, 2006

Capio AB is an European health care group company with operations in English, Spain, France and the Nordic region. The company is owned indirectly by Apax Europe, Nordic Capital and Apax France. The bid corresponds to a total of all shares in Capio for SEK 15.6 billion.

Vinge acted as advisor to Opica AB. Representatives from Vinge included Carl Gustaf De Geer, Göran Nyström, Malin Leffler, Fabian Ekeblad, Carl Wetter, Ola Sandersson, Sara Mindus and Sara Axelsson.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026